Staff Publication: January 2019

  1. Ahmad AE, Kutikov A, Finelli A. Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare? European Urology. 2019 PMID: 30642611.
  2. Al-Hebshi NN, Baraniya D, Chen T, et al. Metagenome Sequencing-Based Strain-Level and Functional Characterization of Supragingival Microbiome Associated with Dental Caries in Children. Journal of Oral Microbiology. 2019;11(1):1557986. PMID: 30671194. PMC6327923.
  3. Al-Kamel A, Al-Hajj WA, Halboub E, Abdulrab S, Al-Tahami K, Al-Hebshi NN. N-Acetyl Cysteine Versus Chlorhexidine Mouthwashes in Prevention and Treatment of Experimental Gingivitis: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Clinical Oral Investigations. 2019 PMID: 30673864.
  4. Al-Mansour Z, Li H, Cook JR, et al. Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin Lymphoma: A Swog 9704 Intergroup Trial Subgroup Analysis. Leukemia & Lymphoma. 2019:1-8. PMID: 30628511.
  5. Bellacosa A, Yen T. Illuminating the Route of Precision Medicine and Inhibitor Discovery: Real-Time Measurement of DNA Repair Capacity with Molecular Beacons. Oncotarget. 2018;9(96):36818-36819. PMID: 30627317. PMC6305151.
  6. Binder P, Wang S, Radu M, et al. Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response. Circulation Research. 2019;124(5):696-711. PMID: 30620686.
  7. Blackwell KL, Zaman K, Qin S, et al. Neratinib in Combination with Trastuzumab for the Treatment of Patients with Advanced Her2-Positive Breast Cancer: A Phase I/II Study. Clinical Breast Cancer. 2018 PMID: 30655172.
  8. Brown AF, Ma GX, Miranda J, et al. Structural Interventions to Reduce and Eliminate Health Disparities. American Journal of Public Health. 2019;109(S1):S72-S78. PMID: 30699019. PMC6356131.
  9. Chen M, Fan L, Zhang SM, et al. LINC01939 Inhibits the Metastasis of Gastric Cancer by Acting as a Molecular Sponge of miR-17-5p to Regulate EGR2 Expression. Cell Death & Disease. 2019;10(2):70. PMID: 30683847. PMC6347617.
  10. Chitalia A, Swoboda DM, McCutcheon JN, Ozdemirli M, Khan N, Cheson BD. Descriptive Analysis of Genetic Aberrations and Cell of Origin in Richter Transformation. Leukemia & Lymphoma. 2019:1-9. PMID: 30632835.
  11. Cohen EEW, Soulieres D, Le Tourneau C, et al. Pembrolizumab Versus Methotrexate, Docetaxel, or Cetuximab for Recurrent or Metastatic Head-and-Neck Squamous Cell Carcinoma (Keynote-040): A Randomised, Open-Label, Phase 3 Study. Lancet. 2019;393(10167):156-167. PMID: 30509740.
  12. Conroy JM, Pabla S, Nesline MK, et al. Next Generation Sequencing of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors. Journal for Immunotherapy of Cancer. 2019;7(1):18. PMID: 30678715. PMC6346512.
  13. Crook JM, Zhang P, Pisansky TM, et al. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer after External Beam Radiation Therapy (NRG Oncology/RTOG-0526). International Journal of Radiation Oncology, Biology, Physics. 2019;103(2):335-343. PMID: 30312717. PMC6368223.
  14. Davis SM, Lepore SJ, Dumenci L. Psychometric Properties and Correlates of a Brief Scale Measuring the Psychological Construct Mattering to Others in a Sample of Women Recovering from Breast Cancer. Quality of Life Research. 2019 PMID: 30684148.
  15. Derweesh IH, Staehler M, Uzzo RG. A Return to the Days of Radical Nephrectomy as the “Gold Standard” for Localized Renal Cell Carcinoma? Not So Fast. European Urology. 2019 PMID: 30655089.
  16. Dmitrieva-Posocco O, Dzutsev A, Posocco DF, et al. Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer. Immunity. 2019;50(1):166-180 e167. PMID: 30650375.
  17. Dumenci L, Perera RA, Keefe FJ, et al. Model-Based Pain and Function Outcome Trajectory Types for Patients Undergoing Knee Arthroplasty: A Secondary Analysis from a Randomized Clinical Trial. Osteoarthritis and Cartilage. 2019 PMID: 30660721.
  18. Falchook G, Coleman RL, Roszak A, et al. Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2019;5(1):e183773. PMID: 30347019.
  19. Fisher JO, Serrano EL, Foster GD, et al. Efficacy of a Food Parenting Intervention for Mothers with Low Income to Reduce Preschooler’s Solid Fat and Added Sugar Intakes: A Randomized Controlled Trial. The International Journal of Behavioral Nutrition and Physical Activity. 2019;16(1):6. PMID: 30654818. PMC6335764.
  20. Frost CJ, Andrulis IL, Buys SS, et al. Assessing Patient Readiness for Personalized Genomic Medicine. J Community Genet. 2019;10(1):109-120. PMID: 29804257. PMC6325047.
  21. Gershman B, Maroni P, Tilburt JC, et al. A National Survey of Radiation Oncologists and Urologists on Prediction Tools and Nomograms for Localized Prostate Cancer. World Journal of Urology. 2019. PMID: 30671637.
  22. Gerson JN, Handorf E, Villa D, et al. Survival Outcomes of Younger Patients with Mantle Cell Lymphoma Treated in the Rituximab Era. Journal of Clinical Oncology. 2019;37(6):471-480. PMID: 30615550.
  23. Ghatalia P, Smith CH, Winer A, et al. Clinical Utilization Pattern of Liquid Biopsies (Lb) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (MCRC) Patients (PTS) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Front Oncol. 2018;8:652. PMID: 30705875. PMC6344461.
  24. Hamy AS, Tury S, Wang X, et al. Celecoxib with Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. Journal of Clinical Oncology. 2019;37(8):624-635. PMID: 30702971.
  25. Holschneider CH, Petereit DG, Chu C, et al. Brachytherapy: A Critical Component of Primary Radiation Therapy for Cervical Cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy. 2019 PMID: 30665713.
  26. Huerta-Chagoya A, Moreno-Macias H, Fernandez-Lopez JC, et al. A Panel of 32 AIMs Suitable for Population Stratification Correction and Global Ancestry Estimation in Mexican Mestizos. BMC Genetics. 2019;20(1):5. PMID: 30621578. PMC6323778.
  27. Jiang X, Finucane HK, Schumacher FR, et al. Shared Heritability and Functional Enrichment across Six Solid Cancers. Nature Communications. 2019;10(1):431. PMID: 30683880. PMC6347624.
  28. Joshi S, Kutikov A. Editorial Comment. The Journal of Urology. 2017;197(2):383-384. PMID: 27821261.
  29. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis Might Reflect Epithelial Lysyl Oxidase Induction by Fibroblast-Derived Tnf-Alpha. J Allergy Clin Immunol. 2018 PMID: 30578874.
  30. Kaur A, Ecker BL, Douglass SM, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2019;9(1):64-81. PMID: 30279173. PMC6328333.
  31. Kishan AU, Wang X, Seiferheld W, et al. Association of Gleason Grade with Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-Analysis. JAMA Oncol. 2019;5(1):91-96. PMID: 3032603.
  32. Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2019;17(1):64-84. PMID: 30659131.
  33. Lafata JE, Shin Y, Flocke SA, et al. Randomised Trial to Evaluate the Effectiveness and Impact of Offering Postvisit Decision Support and Assistance in Obtaining Physician-Recommended Colorectal Cancer Screening: The E-Assist: Colon Health Study-A Protocol Study. BMJ Open. 2019;9(1):e023986. PMID: 30617102. PMC6326296.
  34. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2019;105:137-149. PMID: 30508726.
  35. Mancuso P, Tricarico R, Bhattacharjee V, et al. Thymine DNA Glycosylase as a Novel Target for Melanoma. Oncogene. 2019 PMID: 30674989.
  36. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720. PMC6323553.
  37. Mikropoulos C, Selkirk CGH, Saya S, et al. Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men with Genetic Predisposition. British Journal of Cancer. 2018;118(2):266-276. PMID: 29301143. PMC5785754.
  38. Miller ME, Bleicher RJ, Kaufman CS, et al. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers. Annals of Surgical Oncology. 2019 PMID: 30684159.
  39. Milora KA, Uppalapati SR, Sanmiguel JC, Zou W, Jensen LE. Interleukin-36β Provides Protection against HSV-1 Infection, but Does Not Modulate Initiation of Adaptive Immune Responses. Scientific Reports. 2017;7(1):5799. PMID: 28724920. PMC5517484.
  40. Nam HY, Chandrashekar DS, Kundu A, et al. Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Molecular Cancer Research. 2019;17(1):84-96. PMID: 30131446.
  41. Necchi A, Pond GR, Moschini M, et al. Development of a Prediction Tool for Exclusive Locoregional Recurrence after Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2019;17(1):7-14 e13. PMID: 30292628.
  42. Nicolas E, Demidova EV, Iqbal W, et al. Interaction of Germline Variants in a Family with a History of Early-Onset Clear Cell Renal Cell Carcinoma. Molecular Genetics & Genomic Medicine. 2019:e556. PMID: 30680959.
  43. Pang M, Koop A, Brahmbhatt B, Bartel MJ, Woodward TA. Comparison of Flexible Endoscopic Cricopharyngeal Myectomy and Myotomy Approaches for Zenker Diverticulum Repair. Gastrointest Endosc. 2018 PMID: 30342027.
  44. Pei J, Cooper H, Flieder DB, et al. NEAT1-TfFE3 and KAT6A-TFE3 Renal Cell Carcinomas, New Members of MiT Family Translocation Renal Cell Carcinoma. Modern Pathology. 2019 PMID: 30622287.
  45. Rioux CR, Clapper ML, Cooper HS, et al. Self-Antigen MASH2 Combined with the AS15 Immunostimulant Induces Tumor Protection in Colorectal Cancer Mouse Models. PLoS One. 2019;14(1):e0210261. PMID: 30682058. PMC6347180.
  46. Rogers BB, Cuddahy T, Briscella C, Ross N, Olszanski AJ, Denlinger CS. Oxaliplatin: Detection and Management of Hypersensitivity Reactions. Clinical Journal of Oncology Nursing. 2019;23(1):68-75. PMID: 30682002.
  47. Sheikh S, Saxena D, Tian X, et al. An Integrated Stress Response Agent That Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell Viability. Molecular Cancer Research. 2019 PMID: 30642878.
  48. Simmons AJ, Park R, Sterling NA, et al. Nearly Complete Deletion of BubR1 Causes Microcephaly through Shortened Mitosis and Massive Cell Death. Human Molecular Genetics. 2019 PMID: 30668728.
  49. Singh T, O’Reilly AM. Autophagy as a Beacon and Sentry for Aging Stem Cells. Autophagy. 2019:1-2. PMID: 30661483.
  50. Stinchcombe TE, Fan W, Schild SE, et al. A Pooled Analysis of Individual Patient Data from National Clinical Trials Network Clinical Trials of Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in Elderly Patients Versus Younger Patients. Cancer. 2019;125(3):382-390. PMID: 30343497. PMC6340765.
  51. Swiecki-Sikora AL, Henry KA, Kepka D. HPV Vaccination Coverage among US Teens across the Rural-Urban Continuum. The Journal of Rural Health. 2019 PMID: 30703854.
  52. Whitcomb EA, Tsai YC, Basappa J, et al. Stabilization of P27Kip1/CDKN1B by UBCH7/UBE2L3 Catalyzed Ubiquitinylation: A New Paradigm in Cell-Cycle Control. FASEB J. 2019;33(1):1235-1247. PMID: 30113882. PMC6355086.
  53. Wierda WG, Byrd JC, Abramson JS, et al. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. Journal of the National Comprehensive Cancer Network. 2019;17(1):12-20. PMID: 30659125.
  54. Yao JC, Garg A, Chen D, et al. Genomic Profiling of Nets: A Comprehensive Analysis of the Radiant Trials. Endocrine-related Cancer. 2019 PMID: 30667365.
  55. Yeh I, Jorgenson E, Shen L, et al. Targeted Genomic Profiling of Acral Melanoma. Journal of the National Cancer Institute. 2019 PMID: 30657954.
  56. Yoshida H, Lareau CA, Ramirez RN, et al. The cis-Regulatory Atlas of the Mouse Immune System. Cell. 2019;176(4):897-912 e820. PMID: 30686579.
  57. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. The Laryngoscope. 2018;128(8):1874-1880. PMID: 29238975.
Advertisements

Accessing The Cancer Letter

Fox Chase has an institutional subscription to The Cancer Letter. To gain access, proceed as follows. 

  1. Open Firefox.
    Library materials like The Cancer Letter work best in Firefox. Please, do not use Internet Explorer.
  2. Go to the Talbot Library home page.
  3. In the Quick Links box, click on Cancer Letter.
  4. Type your Fox Chase username and password in the text boxes provided.
  5. On menu located at the top of The Cancer Letter home page, click IP Login.
    Once you click IP Login, the page will reload and Welcome, Fox Chase will appear at the top of the screen.
  6. Click PDF to download the current issue, or
    On the menu at the top of The Cancer Letter home page, click Past Issues.

EndNote X9

EndNote X9 for Mac and Windows is available for download from the Software Download Centre. We encourage all EndNote users to make backup copies of their libraries, uninstall X8, and install X9. We also encourage users to install regular updates to EndNote and Word as they are provided; this is especially true of Mac users. To have EndNote installed on your machine phone the IT Help Desk at x2800.

Over the next several weeks we will updating the EndNote LibGuide and posting about X9 here on our blog. In the meantime, here’s what’s new:

  • Enhanced reference-sharing: The library owner can set read-write access rights for other library users.
  • Manuscript matcher (EndNote and Word): Manuscript matcher uses citations in an existing paper or records in an existing library to suggest journals that might be interested in publishing your work.
  • Four new reference types: Discussion Forum, Multimedia Application, Social Media, and Television Episode.
  • Enhanced integration with Web of Science: EndNote X9 users can access Web of Science records or create a citation report from an EndNote library or group within a library
  • Sharing custom groups: EndNote X9 users can share custom groups with other EndNote Online users from *EndNote desktop.
  • View shared groups: EndNote X9 users can view a list of groups shared through EndNote online from EndNote desktop

*EndNote desktop is the version of EndNote installed on your local machine. EndNote online is the Web version of EndNote.

One-on-one EndNote training is available to Fox Chase employees. For more information about EndNote X9 or to schedule training please phone us at x2711 or email Talbot Library.



Staff Publications: December 2018

  1. Al-Hebshi NN, Nasher AT, Maryoud MY, et al. Inflammatory Bacteriome Featuring Fusobacterium Nucleatum and Pseudomonas Aeruginosa Identified in Association with Oral Squamous Cell Carcinoma. Sci Rep. 2017;7(1):1834. PMID: 28500338. PMC5431832.
  2. Bai T, Chanda AK, Egleston BL, Vucetic S. EHR Phenotyping via Jointly Embedding Medical Concepts and Words into a Unified Vector Space. BMC Med Inform Decis Mak. 2018;18(Suppl 4):123. PMID: 30537974. PMC6290514.
  3. Bair SM, Strelec LE, Feldman TA, et al. Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis. Oncologist. 2018. PMID: 30568021.
  4. Bergman A, Gligorijevic B. Real-Time Imaging of Invadopodia in Tumor Microenvironment Context. (2018) Optics InfoBase Conference Papers, Part F89-MICROSCOPY 2 p.
  5. Cheson BD, O’Brien S, Ewer MS, et al. Optimal Management of Adverse Events from Copanlisib in the Treatment of Patients with Non-Hodgkin Lymphomas. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30584024.
  6. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019;123:174-180. PMID: 30296503.
  7. de Prisco N, Stout E, Font-Burgada J. Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination. Methods Mol Biol. 2019;1905:59-70. PMID: 30536090.
  8. Dignam JJ, Hamstra DA, Lepor H, et al. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2018:JCO1800154. PMID: 30526194.
  9. Dyer KE, Shires DA, Flocke SA, et al. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening. Am J Prev Med. 2018. PMID: 30554975.
  10. Edwards DC, Cahn DB, Reddy M, et al. Incisional Hernia after Cystectomy: Incidence, Risk Factors and Anthropometric Predisposition. Can J Urol. 2018;25(6):9573-9578. PMID: 30553281.
  11. Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma. Clin Adv Hematol Oncol. 2018;16(10):677-686. PMID: 30543598.
  12. Gotlib J, Gerds AT, Bose P, et al. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(12):1500-1537. PMID: 30545997.
  13. Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med. 2018;379(25):2417-2428. PMID: 30575484.
  14. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593. PMC6065537.
  15. Haddad RI, Nasr C, Bischoff L, et al. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429-1440. PMID: 30545990.
  16. Hendifar AE, Petzel MQB, Zimmers TA, et al. Pancreas Cancer-Associated Weight Loss. Oncologist. 2018. PMID: 30591550.
  17. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  18. Heyza JR, Arora S, Zhang H, et al. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 2018;10(11). PMID: 30400270. PMC6267282.
  19. Ito T, Derweesh IH, Ginzburg S, et al. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017;197(1):31-36. PMID: 27418453.
  20. Jones CE, Hammer AM, Cho Y, et al. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia. 2019;21(1):132-145. PMID: 30550871. PMC6293034.
  21. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis May Reflect Epithelial Lysyl Oxidase Induction by Fibroblasts-Derived Tumor Necrosis Factor-Alpha. J Allergy Clin Immunol. 2018. PMID: 30578874.
  22. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  23. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity. Molecular Biology. 2018;52(5):637-647.
  24. Liao L, Alicea-Velazquez NL, Langbein L, et al. High Affinity Binding of H3K14AC through Collaboration of Bromodomains 2, 4, and 5 is Critical for the Molecular and Tumor Suppressor Functions of PBRM1. Mol Oncol. 2018. PMID: 30585695.
  25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an IMRT Patient on a Second Accelerator without Replanning? Med Dosim. 2018;43(4):334-343. PMID: 29287919.
  26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of CGAS-STING Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551. PMC5789800. NIHMS911402.
  27. Lu H, Liu S, Zhang G, et al. Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-Mutant Melanomas. Nature. 2019;565(7738):E4. PMID: 30532003.
  28. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2018;105:137-149. PMID: 30508726.
  29. Magnius L, Taylor J, Mason WS, et al. ICTV Virus Taxonomy Profile: Deltavirus. J Gen Virol. 2018;99(12):1565-1566. PMID: 30311870.
  30. Martin JM, Wu H, Barta SK. Cd30+ T-Cell Lymphoproliferative Disorders. Chin Clin Oncol. 2018. PMID: 30525751.
  31. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720.
  32. Ming M, Wu W, Xie B, et al. XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Mol Cancer Ther. 2018;17(12):2564-2574. PMID: 3051014.
  33. Mortazavi SAR, Kadivar F, Mortazavi SMJ. Comments on, “A Narrative Review of Interventions for Improving Sleep and Reducing Circadian Disruption in Medical Inpatients”. Sleep Med. 2018. PMID: 30503687.
  34. Parham LR, Williams PA, Chatterji P, Whelan KA, Hamilton KE. RNA Regulons Are Essential in Intestinal Homeostasis. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G197-G204. PMID: 30520692.
  35. Pourfarhangi KE, Bayarmagnai B, de la Hoz EC, Cohen A, Gligorijevic B. A Methodology to Investigate the Relationship between Cancer Cells Cell-Cycle Phase and Their Migratory Behaviors. Optics InfoBase Conference Papers, Part F91-TRANSLATIONAL. 2 p. 2018.
  36. Prabhu VV, Madhukar NS, Gilvary C, et al. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2018. PMID: 30559168.
  37. Ramos JD, Wingate JT, Gulati R, et al. Venous Thromboembolism Risk in Patients with Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer. 2017;16(1):e161-e167. PMID: 28923700. PMC5826750.
  38. Redner RL, Beumer JH, Kropf P, et al. A Phase-1 Study of Dasatinib plus All-Trans Retinoic Acid in Acute Myeloid Leukemia. Leuk Lymphoma. 2018;59(11):2595-2601. PMID: 29616864. PMC6201295.
  39. Reese JB, Smith KC, Handorf E, et al. A Randomized Pilot Trial of a Couple-Based Intervention Addressing Sexual Concerns for Breast Cancer Survivors. J Psychosoc Oncol. 2018:1-22. PMID: 30580675.
  40. Reese JB, Sorice KA, Oppenheimer NM, et al. Why Do Breast Cancer Survivors Decline a Couple-Based Intimacy Enhancement Intervention Trial? Transl Behav Med. 2018. PMID: 30544201.
  41. Roethke SK, Ryan JC, Wood SY. Management of Older Patients with Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. J Adv Pract Oncol. 2018;9(1):67-76. PMID: 30564469. PMC6296420.
  42. Roussi P, Miller SM, Giri VN, et al. Effects of a Randomized Trial Comparing Standard and Enhanced Counseling for Men at High Risk of Prostate Cancer as a Function of Race and Monitoring Style. J Health Psychol. 2016;23(14):1359105316671188. PMID: 28810355. PMC5561513.
  43. Shulman RM, Meyer JE, Li T, Howell KJ. External Beam Radiation Therapy (EBRT) for Asymptomatic Bone Metastases in Patients with Solid Tumors Reduces the Risk of Skeletal-Related Events (SRES). Ann Palliat Med. 2018. PMID: 30525770.
  44. Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic Reprogramming of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer Cells with DNA Methyltransferase and Histone Deacetylase Inhibitors. J Exp Clin Cancer Res. 2018;37(1):314. PMID: 30547810. PMC6295063.
  45. Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341. PMID: 30517737. PMC6292796.
  46. White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD. Advanced Pancreatic Cancer Clinical Trials: The Continued Underrepresentation of Older Patients. J Geriatr Oncol. 2018. PMID: 30573201.
  47. Wickersham KE, Hodges TK, Edelman MJ, Song Y, Nan M, Dorsey SG. Differential Gene Expression in Erlotinib-Treated Fibroblasts. Nurs Res. 2018. PMID: 30540703.
  48. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  49. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2019;42(1):46-55. PMID: 29965809.

Staff Publications: November 2018

  1. Abbas AE. Surgical Management of Lung Cancer: History, Evolution, and Modern Advances. Curr Oncol Rep. 2018;20(12):98. PMID: 30421260.
  2. Abboud CN, Lang N, Fung H, et al. Real-World Safety Experience of Tevagrastim/Ratiograstim/Biograstim and Tbo-Filgrastim, Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factors. Support Care Cancer. 2018. PMID: 30443809.
  3. Ablain J, Xu M, Rothschild H, et al. Human Tumor Genomics and Zebrafish Modeling Identify SPRED1 Loss as a Driver of Mucosal Melanoma. Science. 2018;362(6418):1055-1060. PMID: 30385465.
  4. Anari F, O’Neill J, Choi W, et al. Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial. Eur Urol Oncol. 2018;1(1):54-60. PMID: 30420974. PMC6226048. NIHMS966051
  5. Andersen MR, Karlan BY, Drescher CW, et al. False-Positive Screening Events and Worry Influence Decisions About Surgery among High-Risk Women. Health Psychol. 2018. PMID: 30431292.
  6. Andres SF, Williams KN, Plesset JB, et al. IMP1 3′ UTR Shortening Enhances Metastatic Burden in Colorectal Cancer. Carcinogenesis. 2018. PMID: 30407516.
  7. Asghar AM, McIntosh AG, Kutikov A, Chen DY, Geynisman DM. Neoadjuvant Chemotherapy for Penile Cancer Enabling Organ Preservation: A Case of Individualized Management for Bilateral Lymph Node Metastasis and a Bulky Primary Tumor. Urol Case Rep. 2019;23:3-5. PMID: 30505684. PMC6260424.
  8. Banerjee PP, Pang L, Soldan SS, et al. KIR2DL4-HLAG Interaction at Human NK Cell-Oligodendrocyte Interfaces Regulates IFN-γ-Mediated Effects. Mol Immunol. 2018. PMID: 30482463.
  9. Beitler JJ, Ridge JA, Vermorken JB, et al. T4 Laryngeal Cancer with Good Function: Should We Be Reluctant to Treat without Surgery? International Journal of Radiation Oncology Biology Physics. 2018;102(5):1400-1403.
  10. Beri N, Patrick-Miller LJ, Egleston BL, et al. Preferences for in-Person Disclosure: Patients Declining Telephone Disclosure Characteristics and Outcomes in the Multicenter Communication of Genetic Test Results by Telephone Study. Clin Genet. 2018. PMID: 30417332.
  11. Bevelacqua JJ, Mortazavi SMJ. Comments on “Irradiation Effects of MeV Protons on Dry and Hydrated Brassica rapa Seeds”. Life Sci Space Res (Amst). 2018;19:51. PMID: 30482281.
  12. Bevers TB, Helvie M, Bonaccio E, et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(11):1362-1389. PMID: 30442736.
  13. Blackman E, Ashing K, Gibbs D, et al. The Cancer Prevention Project of Philadelphia: Preliminary Findings Examining Diversity among the African Diaspora. Ethn Health. 2018:1-17. PMID: 30453751.
  14. Bleicher RJ, Chang C, Wang CE, et al. Treatment Delays from Transfers of Care and Their Impact on Breast Cancer Quality Measures. Breast Cancer Res Treat. 2018. PMID: 30443881.
  15. Bruinooge SS, Pickard TA, Vogel W, et al. Understanding the Role of Advanced Practice Providers in Oncology in the United States. Jaapa. 2018;31(12):1-12. PMID: 30489397.
  16. Campbell KS, Cohen AD, Pazina T. Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. Front Immunol. 2018;9:2551. PMID: 30455698. PMC6230619. .
  17. Capo-Chichi CD, Cai KQ, Xu XX. Overexpression and Cytoplasmic Localization of caspase-6 Is Associated with Lamin a Degradation in Set of Ovarian Cancers. Biomark Res. 2018;6:30. PMID: 30450209. PMC6208109.
  18. Chang HW, Valieva ME, Safina A, et al. Mechanism of Fact Removal from Transcribed Genes by Anticancer Drugs Curaxins. Sci Adv. 2018;4(11):eaav2131. PMID: 30417101. PMC6221510.
  19. Chien CR, Geynisman DM, Kim B, Xu Y, Shih YT. Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review. Pharmacoeconomics. 2018. PMID: 30467701.
  20. Churilla TM, Chowdhury IH, Handorf E, et al. Comparison of Local Control of Brain Metastases with Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2018. PMID: 30419088.
  21. Clark S, Ebersole B. Understanding the Role of Speech Language Pathologists in Managing Dysphagia. Nursing. 2018;48(12):42-46. PMID: 30461710.
  22. Collins ME, Abrahm JL. Communication Challenges at the Crossroads of Oncology and Palliative Care: Finding a Way Forward When Clinicians Differ on Prognosis. J Palliat Care. 2018:825859718814767. PMID: 30484363.
  23. Correa AF, Uzzo RG. Author Response. Urology. 2018.
  24. D’Avella C, Abbosh P, Pal SK, Geynisman DM. Mutations in Renal Cell Carcinoma. Urol Oncol. 2018. PMID: 30478013.
  25. Del Bene G, Calabro F, Giannarelli D, et al. Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis from the RISC Database. Front Oncol. 2018;8:463. PMID: 30510914. PMC6252384.
  26. Drilon A, Fu S, Patel MR, et al. A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105. Cancer Discov. 2018. PMID: 30487236.
  27. Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of Administrative Data for Comparative Effectiveness Research in the Treatment of Non-Prostate Genitourinary Malignancies. Urol Oncol. 2018;36(4):193-212. PMID: 28867432.
  28. Fatkhullina AR, Peshkova IO, Dzutsev A, et al. An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity. 2018;49(5):943-957 e949. PMID: 30389414. PMC6257980. NIHMS1510832.
  29. Gasoyan H, Tajeu G, Halpern MT, Sarwer DB. Reasons for Underutilization of Bariatric Surgery: The Role of Insurance Benefit Design. Surg Obes Relat Dis. 2018. PMID: 30425002.
  30. Gillison ML, Trotti AM, Harris J, et al. Radiotherapy Plus Cetuximab or Cisplatin in Human Papillomavirus-Positive Oropharyngeal Cancer (Nrg Oncology Rtog 1016): A Randomised, Multicentre, Non-Inferiority Trial. Lancet. 2018. PMID: 30449625.
  31. Hanada Y, Choi AY, Hwang JH, et al. Low Frequency of Lymph Node Metastases in Patients in the United States with Early-Stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria. Clin Gastroenterol Hepatol. 2018. PMID: 30471457.
  32. Handra-Luca A, Wei S. Intrathyroid Cystic Thyroglossal Duct Remnant and Ectopic Thymus: A Fortuitous or Development-Related Association? Surg Today. 2018;48(8):815-818. PMID: 29460127.
  33. Holschneider CH, Petereit DG, Chu C, et al. Brachytherapy: A Critical Component of Primary Radiation Therapy for Cervical Cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Gynecol Oncol. 2018.
  34. Hopper JL, Dite GS, MacInnis RJ, et al. Age-Specific Breast Cancer Risk by Body Mass Index and Familial Risk: Prospective Family Study Cohort (Prof-Sc). Breast Cancer Res. 2018;20(1):132. PMID: 30390716. PMC6215632.
  35. Horwitz EM, Ridge JA, Bruner DW, Movsas B, Pollack A, Fowble B. Gerald E. Hanks, Md, Fastro Obituary. International Journal of Radiation Oncology Biology Physics. 2018;102(5):1393-1395.
  36. Hulse M, Caruso LB, Madzo J, Tan Y, Johnson S, Tempera I. Poly(ADP-Ribose) Polymerase 1 Is Necessary for Coactivating Hypoxia-Inducible Factor-1-Dependent Gene Expression by Epstein-Barr Virus Latent Membrane Protein 1. PLoS Pathog. 2018;14(11):e1007394. PMID: 30395643. PMC6237423.
  37. Ismail HM, Krishnamoorthy N, Al-Dewik N, et al. In Silico and in Vivo Models for Qatari-Specific Classical Homocystinuria as Basis for Development of Novel Therapies. Hum Mutat. 2018. PMID: 30408270.
  38. Karchugina S, Chernoff J. Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay. J Vis Exp. 2018(140). PMID: 30394375. PMC6235567.
  39. Kijima T, Nakagawa H, Shimonosono M, et al. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells. Cell Mol Gastroenterol Hepatol. 2019;7(1):73-91. PMID: 30510992. PMC6260338.
  40. Klingler MJ, Babitz SK, Kutikov A, et al. Assessment of Volume Preservation Performed before or after Partial Nephrectomy Accurately Predicts Postoperative Renal Function: Results from a Prospective Multicenter Study. Urol Oncol. 2018. PMID: 30473205.
  41. Liu JC, Bhayani M, Kuchta K, Galloway T, Fundakowski C. Patterns of Distant Metastasis in Head and Neck Cancer at Presentation: Implications for Initial Evaluation. Oral Oncology. 2019;88:131-136.
  42. Malik R, Luong T, Cao X, et al. Rigidity Controls Human Desmoplastic Matrix Anisotropy to Enable Pancreatic Cancer Cell Spread Via Extracellular Signal-Regulated Kinase 2. Matrix Biol. 2018. PMID: 30412725.
  43. Manley C, Olszanski A. Melanoma in the Bronchus. N Engl J Med. 2018;379(20):e36. PMID: 30428282. https://www.ncbi.nlm.nih.gov/pubmed/30428282.
  44. Masic S, Kutikov A. Robotic Inferior Vena Cava Thrombectomy: Are We Entering the House through an Attic Window? Eur Urol Focus. 2018. PMID: 30415922.
  45. Matulonis UA, Birrer MJ, O’Malley DM, et al. Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Clin Cancer Res. 2018. PMID: 30413525.
  46. Mortazavi SMJ. Re: Presence of Multidrug Resistant Bacteria on Mobile Phones of Healthcare Workers Accelerates the Spread of Nosocomial Infections and Regarded as a Threat to Public Health in Bangladesh. J Microsc Ultrastruct. 2018;6(4):215-216. PMID: 30464896. PMC6206753.
  47. Pei J, Al-Saleem T, Uzzo RG, Dulaimi E, Testa JR, Wei S. Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-Grade Renal Cell Carcinoma with Clear Cell and Papillary Features. Appl Immunohistochem Mol Morphol. 2018. PMID: 30499818.
  48. Ragin C, Banydeen R, Zhang C, et al. Breast Cancer Research in the Caribbean: Analysis of Reports from 1975 to 2017. J Glob Oncol. 2018(4):1-21. PMID: 30481085.
  49. Roach M, Moughan J, Lawton CAF, et al. Sequence of Hormonal Therapy and Radiotherapy Field Size in Unfavourable, Localised Prostate Cancer (NRG/RTOG 9413): Long-Term Results of a Randomised, Phase 3 Trial. Lancet Oncol. 2018;19(11):1504-1515. PMID: 30316827.
  50. Rogers HL, Dumenci L, Epstein RM, Siminoff LA. Impact of Patient Gender and Race and Physician Communication on Colorectal Cancer Diagnostic Visits in Primary Care. J Womens Health (Larchmt). 2018. PMID: 30489201.
  51. Shafi AA, Schiewer MJ, de Leeuw R, et al. Patient-Derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol. 2018;1(4):325-337. PMID: 30467556. PMC6241309. NIHMS972310.
  52. Streiff MB, Holmstrom B, Angelini D, et al. Nccn Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018;16(11):1289-1303. PMID: 30442731.
  53. Terry MB, Daly MB, Phillips KA, et al. Risk-Reducing Oophorectomy and Breast Cancer Risk across the Spectrum of Familial Risk. J Natl Cancer Inst. 2018. PMID: 30496449.
  54. Tomalka AG, Resto-Garay I, Campbell KS, Popkin DL. In Vitro Evidence That Combination Therapy with CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2HI Memory T Cells. Front Immunol. 2018;9:2552. PMID: 30455699. PMC6230627.
  55. Tripathi A, Plimack ER. Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions. Curr Urol Rep. 2018;19(12):109. PMID: 30406502.
  56. Vrakas CN, Herman AB, Ray M, Kelemen SE, Scalia R, Autieri MV. Rna Stability Protein ILF3 Mediates Cytokine-Induced Angiogenesis. FASEB J. 2018:fj201801315R. PMID: 30383449.
  57. Zhang H, Pandey S, Travers M, et al. Targeting Cdk9 Reactivates Epigenetically Silenced Genes in Cancer. Cell. 2018;175(5):1244-1258 e1226. PMID: 30454645. PMC6247954. NIHMS1510720.

Read More »

Staff Publications: October 2018

  1. Amin A, Plimack ER, Ernstoff MS, et al. Safety and Efficacy of Nivolumab in Combination with Sunitinib or Pazopanib in Advanced or Metastatic Renal Cell Carcinoma: The Checkmate 016 Study. J Immunother Cancer. 2018;6(1):109. PMID: 30348216. PMC6196426.
  2. Arora S, Heyza JR, Chalfin EC, Ruch RJ, Patrick SM. Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling. Cancers (Basel). 2018;10(10). PMID: 30279363. PMC6210410.
  3. Badar T, Hamadani M, Bachanova V, et al. Efficacy of Salvage Chemotherapy in Diffuse Large B Cell Lymphoma with Primary Treatment Failure According to Putative Cell of Origin. Leuk Lymphoma. 2018:1-7. PMID: 30277110.
  4. Barone FC, Marcinkiewicz C, Li J, et al. Pilot Study on Biocompatibility of Fluorescent Nanodiamond-(NV)-Z~800 Particles in Rats: Safety, Pharmacokinetics, and Bio-Distribution (Part III). Int J Nanomedicine. 2018;13:5449-5468. PMID: 30271140. PMC6149985.
  5. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We CAST It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.
  6. Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. RelTime Relaxes the Strict Molecular Clock Throughout the Phylogeny. Genome Biol Evol. 2018;10(6):1631-1636. PMID: 29878203. PMC6022624. .
  7. Bevelacqua JJ, Mortazavi SMJ. Commentary Regarding “on-Orbit Sleep Problems of Astronauts and Countermeasures”. Mil Med Res. 2018;5(1):38. PMID: 30376883. PMC6208067.
  8. Chakraborty H, Mogurampelly S, Yadav VK, Waghmare UV, Klein ML. Phonons and Thermal Conducting Properties of Borocarbonitride (BCN) Nanosheets. Nanoscale. 2018;10(47):22148-22154. PMID: 30357208.
  9. Chauhan N, Bukovcan J, Boucher E, et al. Intra-Arterial Therasphere Yttrium-90 Glass Microspheres in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial. Journal of Medical Internet Research. 2018;20(8):e11234. PMID: 30111528. PMC6115595.
  10. Chernoff J. How to Get and Keep Your Lab Funded. Mol Biol Cell. 2018;29(21):2519-2521. PMID: 30325287.
  11. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2018. PMID: 30296503.
  12. Cristescu R, Mogg R, Ayers M, et al. Pan-Tumor Genomic Biomarkers for PD-1 Checkpoint Blockade-Based Immunotherapy. Science. 2018;362(6411). PMID: 30309915.
  13. Crook JM, Zhang P, Pisansky TM, et al. A Prospective Phase Ii Trial of Trans-Perineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer after External Beam Radiotherapy (NRG Oncology/RTOG -0526). Int J Radiat Oncol Biol Phys. 2018. PMID: 30312717.
  14. Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 2.2018 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(10):1216-1247. PMID: 30323092.
  15. Doss M. Letter by Doss Regarding Article, “Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and Malignancy Risk in Adults with Congenital Heart Disease”. Circulation. 2018;138(13):1375-1376. PMID: 30354420.
  16. Dow M, Pyke RM, Tsui BY, et al. Integrative Genomic Analysis of Mouse and Human Hepatocellular Carcinoma. Proc Natl Acad Sci U S A. 2018;115(42):E9879-e9888. PMID: 30287485. PMC6196518.
  17. Falchook G, Coleman RL, Roszak A, et al. Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018:e183773. PMID: 30347019.
  18. Feldman G, Kappes D, Mookerjee-Basu J, Freeman T, Fertala A, Parvizi J. Novel Mutation in Teneurin 3 Found to Co-Segregate in All Affecteds in a Multi-Generation Family with Developmental Dysplasia of the Hip. J Orthop Res. 2018. PMID: 30273960.
  19. Feofanov AV, Andreeva TV, Studitsky VM, Kirpichnikov MP. Reversibility of Structural Rearrangements in Mononucleosomes Induced by Ionic Strength. Moscow University Biological Sciences Bulletin. 2018;73(3):157-161.
  20. Gadgeel SM, Stevenson JP, Langer CJ, et al. Pembrolizumab and Platinum-Based Chemotherapy as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer: Phase 1 Cohorts from the KEYNOTE-021 Study. Lung Cancer. 2018;125:273-281. PMID: 30429032.
  21. Ge Y, Borne E, Stewart S, et al. Simulations of the Regulatory Act Domain of Human Phenylalanine Hydroxylase Unveil Its Mechanism of Phenylalanine Binding. J Biol Chem. 2018. PMID: 30287685.
  22. Gershman B, Bukavina L, Chen Z, et al. The Association of Robot-Assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs. Eur Urol Focus. 2018. PMID: 30361146.
  23. Ghatalia P, Koenigsberg R, Pisarcik D, Handorf EA, Geynisman DM, Zibelman M. The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the Clinicaltrials.Gov Website. Kidney Cancer. 2017;1(2):151-159. PMID: 30334017. PMC6179107.
  24. Ghatalia P, Rathmell WK. Systematic Review: Clearcode 34 – a Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC). Kidney Cancer. 2018;2(1):23-29. PMID: 30320241. PMC6176730. NIHMS935715..
  25. Greco F, Autorino R, Altieri V, et al. Ischemia Techniques in Nephron-Sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes. Eur Urol. 2018. PMID: 30327272.
  26. Haas NB, Uzzo RG. Perioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What’s Next? J Clin Oncol. 2018:Jco2018789131. PMID: 30372398. .
  27. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. Journal of Urology. 2018;199(3):649-654. PMID: 28941921.
  28. Herman AB, Autieri MV. Cardiovascular Disease, Inflammation, and MRNA Stability. Aging (Albany NY). 2018;10(11):3046-3047. PMID: 30365397.
  29. Hota P, Dass C, Erkmen C, Donuru A, Kumaran M. Poststernotomy Complications: A Multimodal Review of Normal and Abnormal Postoperative Imaging Findings. AJR: Am J Roentgenol. 2018;211(6):1-12. PMID: 30300004.
  30. Johnson C, Drummer Ct, Virtue A, et al. Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity. Front Physiol. 2018;9:1297. PMID: 30369883. PMC6194169.
  31. Jung K, Park JC, Kang H, Brandes JC. Androgen Deprivation Therapy Is Associated with Decreased Second Primary Lung Cancer Risk in the United States Veterans with Prostate Cancer. Epidemiol Health. 2018;40:e2018040. PMID: 30121970. PMC6232654.
  32. Kalemkerian GP, Loo BW, Jr., Akerley W, et al. Nccn Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(10):1171-1182. PMID: 30323087.
  33. Kasimova MA, Yazici AT, Yudin Y, et al. A Hypothetical Molecular Mechanism for Trpv1 Activation That Invokes Rotation of an S6 Asparagine. J Gen Physiol. 2018;150(11):1554-1566. PMID: 30333107. PMC6219692.
  34. Kaur A, Ecker BL, Douglass SM, et al. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov. 2018. PMID: 30279173.
  35. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. [HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity]. Mol Biol (Mosk). 2018;52(5):737-749. PMID: 30363049.
  36. Kupfer SS, Lubner S, Coronel E, et al. Adherence to Postresection Colorectal Cancer Surveillance at National Cancer Institute-Designated Comprehensive Cancer Centers. Cancer Med. 2018;7(11):5351-5358. PMID: 30338661. PMC6247039.
  37. Liao L, Liu ZZ, Langbein L, et al. Multiple Tumor Suppressors Regulate a HIF-Dependent Negative Feedback Loop via ISGF3 in Human Clear Cell Renal Cancer. Elife. 2018;7. PMID: 30355451. PMC6234029.
  38. Liu Z, Chen M, Xie LK, et al. CLCA4 Inhibits Cell Proliferation and Invasion of Hepatocellular Carcinoma by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling. Aging (Albany NY). 2018;10(10):2570-2584. PMID: 30312171. PMC6224236.
  39. Localio AR, Stack CB, Meibohm AR, et al. Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions. Ann Intern Med. 2018;169(8):577-578. PMID: 30304363.
  40. Mazor AM, Mateo AM, Demora L, et al. Breast Conservation Versus Mastectomy in Patients with T3 Breast Cancers (> 5 Cm): An Analysis of 37,268 Patients from the National Cancer Database. Breast Cancer Res Treat. 2018. PMID: 30343456.
  41. Mookerjee-Basu J, Hua X, Ge L, et al. Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age. Mol Biol Evol. 2018. PMID: 30295892.
  42. Moore HCF, Unger JM, Phillips KA, et al. Final Analysis of the Prevention of Early Menopause Study (Poems)/Swog Intergroup S0230. J Natl Cancer Inst. 2018. PMID: 30371800.
  43. Myers RE, Stello B, Daskalakis C, et al. Decision Support and Navigation to Increase Colorectal Cancer Screening among Hispanic Patients. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 30333221.
  44. Necchi A, Pond GR, Moschini M, et al. Development of a Prediction Tool for Exclusive Locoregional Recurrence after Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2018. PMID: 30292628.
  45. Nieborowska-Skorska M, Maifrede S, Ye M, et al. Non-Nad-Like Parp1 Inhibitor Enhanced Synthetic Lethal Effect of Nad-Like Parp Inhibitors against Brca1-Deficient Leukemia. Leuk Lymphoma. 2018:1-4. PMID: 30277116.
  46. O’Neil PT, Machen AJ, Thompson JA, et al. Constructing Kinetically Controlled Denaturation Isotherms of Folded Proteins Using Denaturant-Pulse Chaperonin Binding. Methods Mol Biol. 2019;1873:293-304. PMID: 30341618. PMC6196737. NIHMS972764.
  47. Patel RS, Wen KY, Aggarwal R. Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States. Med Sci (Basel). 2018;6(4). PMID: 30355962.
  48. Putatunda R, Zhang Y, Li F, Yang XF, Barbe MF, Hu W. Adult Neurogenic Deficits in HIV-1 Tg26 Transgenic Mice. J Neuroinflammation. 2018;15(1):287. PMID: 30314515. PMC6182864.
  49. Qian F, Wang S, Mitchell J, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. J Natl Cancer Inst. 2018. PMID: 30312457.
  50. Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High Rate of over-Staging of Barrett’s Neoplasia with Endoscopic Ultrasound: Systemic Review and Meta-Analysis. Dig Liver Dis. 2018;50(5):438-445. PMID: 29573963.
  51. Reese JB, Sorice K, Lepore SJ, Daly MB, Tulsky JA, Beach MC. Patient-Clinician Communication About Sexual Health in Breast Cancer: A Mixed-Methods Analysis of Clinic Dialogue. Patient Educ Couns. 2018. PMID: 30314828.
  52. Rice SR, Molitoris JK, Vyfhuis MAL, et al. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients with Non-Small-Cell Lung Cancer at Diagnosis. Clin Lung Cancer. 2018. PMID: 30337268.
  53. Ristau BT, Smaldone MC. Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care. Curr Urol Rep. 2018;19(12):100. PMID: 30357590.
  54. Roach M, Moughan J, Lawton CAF, et al. Sequence of Hormonal Therapy and Radiotherapy Field Size in Unfavourable, Localised Prostate Cancer (NRG/RTOG 9413): Long-Term Results of a Randomised, Phase 3 Trial. Lancet Oncol. 2018;19(11):1504-1515. PMID: 30316827.
  55. Russell Localio A, Stack CB, Meibohm AR, et al. Inappropriate Statistical Analysis and Reporting in Medical Research: Perverse Incentives and Institutional Solutions. Ann Intern Med. 2018;169(8):577-578. PMID: 30304363.
  56. Schwartz LA, Henry-Moss D, Egleston B, et al. Preventative Health and Risk Behaviors among Adolescent Girls with and without Family Histories of Breast Cancer. J Adolesc Health. 2018. PMID: 30301677.
  57. Sha X, Hoffman B, Liebermann DA. Loss of Gadd45b Accelerates BCR-ABL-Driven CML. Oncotarget. 2018;9(70):33360-33367. PMID: 30279966. PMC6161793.
  58. Shaytan AK, Xiao H, Armeev GA, et al. Structural Interpretation of DNA-Protein Hydroxyl-Radical Footprinting Experiments with High Resolution Using Hydroid. Nat Protoc. 2018;13(11):2535-2556. PMID: 30341436.
  59. Stinchcombe TE, Fan W, Schild SE, et al. A Pooled Analysis of Individual Patient Data from National Clinical Trials Network Clinical Trials of Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in Elderly Patients Versus Younger Patients. Cancer. 2018. PMID: 30343497.
  60. Stout MC, Campbell PM. Raspecting the Oncogene: New Pathways to Therapeutic Advances. Biochem Pharmacol. 2018;158:217-228. PMID: 30352234.
  61. Su F, Myers VD, Knezevic T, et al. Bcl-2-Associated Athanogene 3 Protects the Heart from Ischemia/Reperfusion Injury. JCI Insight. 2016;1(19):e90931. PMID: 27882354. PMC5111510.
  62. Sun Z, Zheng L, Chen M, Klein ML, Paesani F, Wu X. Electron-Hole Theory of the Effect of Quantum Nuclei on the X-Ray Absorption Spectra of Liquid Water. Phys Rev Lett. 2018;121(13):137401. PMID: 30312094.
  63. Timmermans S, Yang A, Gardner M, et al. Does Patient-Centered Care Change Genital Surgery Decisions? The Strategic Use of Clinical Uncertainty in Disorders of Sex Development Clinics. J Health Soc Behav. 2018;59(4):22146518802460. PMID: 30303019.
  64. Twardowski PW, Tangen CM, Wu X, et al. Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107. Kidney Cancer. 2017;1(2):123-132. PMID: 30334014. PMC6179121.
  65. Tyner JW, Tognon CE, Bottomly D, et al. Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature. 2018;562(7728):526-531. PMID: 30333627. PMC6280667.
  66. Upshaw JN, O’Neill A, Carver JR, et al. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clin Colorectal Cancer. 2018. PMID: 30348619.
  67. Wheeler DC, Jones RM, Schootman M, Nelson EJ. Explaining Variation in Elevated Blood Lead Levels among Children in Minnesota Using Neighborhood Socioeconomic Variables. Sci Total Environ. 2019;650(Pt 1):970-977. PMID: 30308871.
  68. Wiest DL. Gadd45 Stress Sensors in Suppression of Leukemia. Oncotarget. 2018;9(76):34191-34192. PMID: 30344933. PMC6188131.
  69. Zhang F, Tapera TM, Gou J. Application of a New Dietary Pattern Analysis Method in Nutritional Epidemiology. BMC Med Res Methodol. 2018;18(1):119. PMID: 30373530. PMC6206725.
  70. Zhang S, Taylor AK, Huang X, et al. Venous Thromboembolism Laboratory Testing (factor V Leiden and factor II C.*97G>A), 2018 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018. PMID: 30297698.